Cargando…
Aerosolized Delivery of Antifungal Agents
Pulmonary infections caused by Aspergillus species are associated with significant morbidity and mortality in immunocompromised patients. Although the treatment of pulmonary fungal infections requires the use of systemic agents, aerosolized delivery is an attractive option in prevention because the...
Autores principales: | Le, Jennifer, Schiller, Daryl S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868999/ https://www.ncbi.nlm.nih.gov/pubmed/20502511 http://dx.doi.org/10.1007/s12281-010-0011-0 |
Ejemplares similares
-
Assessment and Development of the Antifungal Agent Caspofungin for Aerosolized Pulmonary Delivery
por: Yu, Iching G., et al.
Publicado: (2021) -
Design and Characterization of Chitosan Nanoformulations for the Delivery of Antifungal Agents
por: Calvo, Natalia L., et al.
Publicado: (2019) -
Bacillus subtilis engineered for topical delivery of an antifungal agent
por: Montgomery, Veronica A., et al.
Publicado: (2023) -
Preliminary investigation tests of novel antifungal topical aerosol
por: Kapadia, Monali M., et al.
Publicado: (2012) -
Chalcone derivatives as potential antifungal agents: Synthesis, and antifungal activity
por: Gupta, Deepa, et al.
Publicado: (2015)